Roberti G, Tanga L, Manni G, Riva I, Verticchio AC, Berardo F, Carnevale C, Oddone F. Tear Film, Conjunctival and Corneal Modifications Induced by Glaucoma Treatment.
Curr Med Chem 2019;
26:4253-4261. [PMID:
31099319 DOI:
10.2174/0929867326666190517111823]
[Citation(s) in RCA: 8] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/10/2018] [Revised: 03/18/2019] [Accepted: 03/29/2019] [Indexed: 11/22/2022]
Abstract
Ocular surface disease is characterized by tear film instability and histopathologic and clinical changes of the ocular surface. Glaucoma patients often suffer from ocular surface disease caused by the chronic use of preserved medical treatment to reduce intraocular pressure. Benzalkonium chloride is the preservative most frequently used in glaucoma medications. Its effect on tear film, conjunctiva and cornea and the consequences in glaucoma management are discussed in this mini-review.
Collapse